London, UK 21 May 2018 –GSK today announced it has received approval from the US Food and Drug Administration (FDA) for the use of Arnuity Ellipta (fluticasone furoate) a once-daily inhaled corticosteroid (ICS) medicine for the maintenance…Original Article
GSK Receives FDA Approval of Arnuity Ellipta for Asthma in Children From 5 Years of Age
